Kathleen M. Whalen - 05 Feb 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP & Chief Ethics Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
05 Feb 2024
Net transactions value
-$623,854
Form type
4
Filing time
07 Feb 2024, 19:45:08 UTC
Previous filing
02 Feb 2024
Next filing
13 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $174,646 +2,510 +24% $69.58 12,760 05 Feb 2024 Direct
transaction HCA Common Stock Options Exercise $331,118 +4,040 +32% $81.96 16,800 05 Feb 2024 Direct
transaction HCA Common Stock Options Exercise $202,320 +2,000 +12% $101.16 18,800 05 Feb 2024 Direct
transaction HCA Common Stock Tax liability $1,331,939 -4,288 -23% $310.62 14,512 05 Feb 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -2,510 -100% $0.000000* 0 05 Feb 2024 Common Stock 2,510 $69.58 Direct F1
transaction HCA Stock Appreciation Right Options Exercise $0 -4,040 -100% $0.000000* 0 05 Feb 2024 Common Stock 4,040 $81.96 Direct F2
transaction HCA Stock Appreciation Right Options Exercise $0 -2,000 -40% $0.000000 3,040 05 Feb 2024 Common Stock 2,000 $101.16 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
F2 The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018.
F3 The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.